Regulatory Challenges in the CIS and Russia - TOPRA In CEE Webinar
November 22, 2023
Are You Ready for 2021 EAEU Regulatory Changes?
Effective as of January 10, 2021, the registration of medicines in the Russian Federation carries out only in accordance with EAEU rules (Decision of the EEC Council No. 128 of December 23, 2020).
For other EAEU countries, the registration of medicines under national procedures has been extended until July 1, 2021.
Inpharmatis is an international consulting company with more than 15 years’ experience in EAEU, CIS, and EU markets in the field of regulatory services for pharmaceutical companies.
If you want to find out more information about EAEU registration rules, please contact us at info@inpharmatis.com.


Особенности выбора типа Пользовательского тестирования листка-вкладыша в ЕАЭС
November 01, 2023
Features of Choosing the Type of PIL RUT in EAEU
November 01, 2023
PIL Readability User Testing in EAEU Special Autumn Offer
October 25, 2023
Специальное Осеннее Предложение по пользовательскому тестированию листка-вкладыша
October 24, 2023
PIL Readability Testing is Mandatory in EAEU
February 15, 2022
Пользовательское тестирование по ЕАЭС – обязательная процедура
February 14, 2022
One More Inpharmatis Team Member Gets PhD in Pharmaceutical Sciences
January 27, 2022
В штате Inpharmatis стало на одного доктора фармацевтических наук больше
January 27, 2022
Pharma 4.0: Data-Driven Regulation
January 18, 2022